local_hospital

Vital Medical Center

Address
lock Available on a paid plan

Immune System Diseases and Rheumatology

At Vital Medical Center in Veszprem, a large share of the clinical trial work focuses on autoimmune and inflammatory diseases, especially rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and polymyalgia rheumatica. These studies are designed to test new treatment options, compare them with existing therapies, and better understand how to reduce pain, stiffness, and disease activity.

  • Research on rheumatoid arthritis includes studies of symptom control, joint protection, and long-term treatment safety.
  • Psoriatic arthritis trials are evaluating therapies aimed at easing joint inflammation and improving daily function.
  • Axial spondyloarthritis and related conditions are being studied to find better ways to manage ongoing inflammation and mobility problems.
  • Polymyalgia rheumatica research is exploring approaches to maintain remission and reduce relapses.

The site is also involved in studies that assess how well treatments work after prior therapy has not been enough, helping guide more personalized care for people with chronic rheumatic diseases.

Skin and Connective Tissue Diseases

Another important area of research at Vital Medical Center is dermatology, with trials centered on plaque psoriasis and atopic dermatitis. These studies aim to improve skin symptom control, reduce inflammation, and evaluate whether new therapies can offer better relief for people living with moderate to severe disease.

  • Plaque psoriasis studies are testing treatments for skin clearance, symptom reduction, and durability of response.
  • Atopic dermatitis research focuses on easing itching, redness, and overall skin irritation.
  • Some trials look at patients with more challenging forms of psoriasis, including involvement of special areas or higher body weight.
  • Several studies also examine the long-term safety and tolerability of emerging therapies for chronic skin disease.

This work reflects a strong focus on finding better options for people whose skin and connective tissue diseases remain difficult to manage with standard care.

Immune System Processes and Systemic Lupus Erythematosus

The center also contributes to research on immune system processes through multiple studies in systemic lupus erythematosus SLE. These trials are intended to measure whether new therapies can lower disease activity, improve overall control, and support safer long-term treatment for people with this complex autoimmune condition.

  • SLE trials are evaluating treatments for adults with moderate to severe disease activity.
  • Research includes efforts to improve symptom control and reduce flare-related burden.
  • Some studies focus on treatment effectiveness in patients already receiving standard lupus care.
  • Long-term follow-up is also being used to better understand safety and sustained benefit.

This area shows the site’s interest in advancing care for difficult autoimmune diseases where treatment response can vary widely.

Musculoskeletal Diseases and Joint Disorders

Research at Vital Medical Center also includes trials in musculoskeletal diseases, particularly knee osteoarthritis. These studies are focused on easing pain, improving movement, and comparing treatment approaches that may help people with joint damage and chronic discomfort.

  • Knee osteoarthritis studies are examining ways to reduce pain and improve function.
  • Some trials compare different treatment options to see which may offer better symptom relief.
  • Research in this area is aimed at supporting quality of life for people with long-standing joint problems.
  • Safety and tolerability remain important goals alongside symptom improvement.

Together, these studies add a practical orthopedic and rheumatologic dimension to the site’s broader clinical research portfolio.

Site Overview

assignment
24
connected trials
corporate_fare
17
sponsors
science
38
IMPs

Activity Indicator

Last 6 months

0
Trials started
-100% vs previous period.
1
Trials started 6–12 months ago
24
Total trials linked
Highly Active
trending_downDeclining-100%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 4 therapeutic areas and 15 of 38 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
7
Sponsors (total)
17
Active sponsors
6

Sponsor Network

Top 6 by active trials.

lock +5 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +4 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 332 other sites in Hungary

description
Trial volume
24
Outperforms 84% of sites
public
Therapeutic diversity
4areas
Outperforms 76% of sites
groups
Sponsor diversity
17sponsors
Outperforms 88% of sites

Therapeutic Area Benchmark — Hungary

Select a therapeutic area to compare against other sites in Hungary.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Hungary

Market Share

Country: Hungary

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Vital Medical Center

lock Showing 1 of 24 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
22104: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2b/3 Study to Evaluate the Efficacy and Safety of Izokibep in Subjects with Active Psoriatic ArthritisAcelyrin Inc.Phase IVNot RecruitingApr 2023Oct 2024

IMP list

lock Showing 1 of 38 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Jnj-772421132Unknown2023-12-052023-12-19

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.